Trial Profile
A Phase III registrational trial of nepafenac
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- 21 Sep 2018 New trial record
- 04 Sep 2018 According to a Mati Therapeutics media release, the company expects to initiate the Phase III registration study in 2019.